Amide proton transfer (APT) imaging is based on the chemical exchange between free bulk water protons and the amide protons (-NH) of endogenous mobile proteins and peptides in tissue[1]. Nan Meng et al suggested that APTw imaging can be used for the differential diagnosis of benign and malignant breast lesions[2]. A simple sample study has shown that APTw MRI provides a possible biomarker for assessing chemotherapy response in human breast cancer patients on 3T MRI[3]. This study aims to explore the feasibility of APTw-MRI in early evaluation of pathological complete response to NAC in molecular subtyping of breast cancer
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords